Effects of rectal indomethacin in the prevention of post-ERCP pancreatitis;Az indometacin szerepe az endoszkópos retrográd cholangiopancreatographiát követo akut pancreatitis prevenciójában

Orvosi Hetilap

Volumn 153, Issue 25, 2012, Pages 990-996

  Döbrönte, Zoltán ^a,c   Toldy, Erzsébet ^b,c   Márk, Levente ^a   Sarang, Krisztina ^a   Lakner, Lilla ^a  

^a Gasztroenterológiai és Belgyógyászati Osztály ^*  (Hungary)

^b Kozponti Laboratorium   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

endoscopic retrograde cholangiopancreatography; hyperamylasemia; indomethacin; non steroidal anti inflammatory drugs; post ERCP pancreatitis

Indexed keywords

AMYLASE; INDOMETACIN; PLACEBO;

ADULT; AMYLASE BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; HYPERAMYLASEMIA; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ACUTE DISEASE; ADMINISTRATION, RECTAL; AGE FACTORS; AGED; AGED, 80 AND OVER; AMYLASES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; BODY MASS INDEX; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HUMANS; HUNGARY; INCIDENCE; INDOMETHACIN; MALE; MIDDLE AGED; PANCREATITIS; PROSPECTIVE STUDIES; SEX FACTORS; SUPPOSITORIES; TREATMENT FAILURE;

EID: 84862878559     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2012.29403     Document Type: Review

References (26)

1. Freeman, M. L., Guda, M. N.: Prevention of post-ERCP pancreatitis. A comprehensive review. Gastrointest. Endosc., 2004, 59, 845-864. (Pubitemid 38879313)
2. Dumonceau, J.-M., Andriulli, A., Deviere, J., et al.: European Society of Gastrointestinal Endoscopy (ESGE) guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy, 2010, 42, 503-515.
3. Wagh, M. S., Sherman, S.: Indomethacin for post-ERCP pancreatitis prophylaxis. Another attempt at holy grail. Am. J. Gastroenterol., 2007, 102, 984-986. (Pubitemid 46698238)
4. Senol, A., Ulku, S., Halil, D.: Efficacy of intramuscular diclofenac and fl uid replacement in prevention of post-ERCP pancreatitis. World J. Gastroenterol., 2009, 15, 3999-4004.
5. Rabenstein, T., Hahn, E. G.: Post-ERCP pancreatitis. New momentum. Endoscopy, 2002, 34, 325-329.
6. Döbrönte, Z.: Endoscopic retrograde cholangiopancreatography (ERCP) related acute pancreatitis. In: Acute pancreatitis. Ed.: Rod rigo, L. InTech, Rijeka, 2011, 197-214.
7. Lankisch, P. K., Koop, H., Winckler, K., et al.: Indomethacin treatment of acute experimental pancreatitis in the rat. Scand. J. Gastroenterol., 1978, 13, 629-633. (Pubitemid 9003867)
8. Wildenhain, P. M., Melhem, M. F., Birsic, W. I., et al.: Acute hemorrhagic pancreatitis in mice: improved survival after indomethacin administration. Digestion, 1989, 44, 41-51. (Pubitemid 20009464)
9. Murray, B., Carter, R., Imrie, C., et al.: Indomethacin may reduce the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology, 2003, 124, 1786-1791.
10. Sotoudehmanesh, R., Khatibian, M., Kolahdoozan, S., et al.: Diclofenac reduces the incidence and severity of acute pancreatitis after ERCP. Am. J. Gastroenterol., 2007, 102, 978-983. (Pubitemid 46698240)
11. Koshbaten, M., Khorram, H., Madad, L., et al.: Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. J. Gastroenterol. Hepatol., 2008, 23, e11-e16. (Pubitemid 352019420)
12. Montano Loza, A., Garcia Correa, J., Gonzales Ojeda, A., et al.: Effect of administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secundary pancreatitis episodes. Rev. Esp. Enferm. Dig., 2007, 99, 330-336.
13. Elmunzer, B. J., Waljee, A. K., Elta, G. H., et al.: A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut, 2008, 57, 1262-1267.
14. Zhang, M.-H., Xia, H., Chen, Y.-P.: Rectal administration of NSAIDs in prevention of post-ERCP pancreatitis: a complementary meta-analysis. Gut, 2008, 57, 1632-1633.
15. Dai, H.-F., Wang, X.-W, Zhao, K.: Role of nonsteroideal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: a meta-analysis. Hepatobiliary Pancreat. Dis. Int., 2009, 8, 11-16.
16. Dumonceau, J. M., Rigaux, J., Kahaleh, M., et al.: Prophylaxis of post-ERCP pancreatitis: a practice survey. Gastrointest. Endosc., 2010, 71, 934-939.
17. Dumonceau, J. M.: Endoscopy essentials. Biliary endoscopic retrograde cholangiopancreatography. Endoscopy, 2010, 42, 58-61.
18. Cotton, P. B., Lehman, G., Vennes, J., et al.: Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest. Endosc., 1991, 37, 383-393.
19. Andrulli, A., Forlano, B., Napolitano, G., et al.: Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefi ts and associated risks. Digestion, 2007, 75, 156-163. (Pubitemid 47343973)
20. Singh, P., Das, A., Isenberg, G., et al.: Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest. Endosc., 2004, 60, 544-550. (Pubitemid 39311536)
21. Sofuni, A., Maguchi, H., Itoi, T., et al.: Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin. Gastroenterol. Hepatol., 2007, 5, 1339-1346. (Pubitemid 350019054)
22. Freeman, M. L., Overby, C., Qi, D.: Pancreatic stent insertion: consequences of failure and results of a modifi ed technique to maximize success. Gastrointest. Endosc., 2004, 59, 8-14. (Pubitemid 38095500)
23. Das, A., Singh, P., Sivak, M. V., et al.: Pancreatic stent-placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest. Endosc., 2007, 65, 960-968. (Pubitemid 46783815)
24. Cheon, Y. K., Cho, K. B., Watkins, J. L., et al.: Efficacy of diclofenac in prevention of post-ERCP pancreatitis in predominantly high risk patients: a randomised double-blind prospective trial. Gastrointest. Endosc., 2007, 66, 1126-1132. (Pubitemid 350179792)
25. Wang, P., Li, Z.-S., Liu, F., et al.: Risk factors for ERCP related complications: a prospective multicenter study. Am. J. Gastroenterol., 2009, 104, 31-40.
26. Katsinelos, P., Fasoulas, K., Paroutoglou, G., et al.: Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomised, double-blind, placebo-controlled trial. Endoscopy, 2012, 44, 53-59.